Phase I/II study of gefitinib (Iressa(®)) and vorinostat (IVORI) in previously treated patients with advanced non-small cell lung cancer
about
Epigenetic treatment of solid tumours: a review of clinical trialsThe histone deacetylase inhibitor SAHA induces HSP60 nitration and its extracellular release by exosomal vesicles in human lung-derived carcinoma cells.Synergistic activity of vorinostat combined with gefitinib but not with sorafenib in mutant KRAS human non-small cell lung cancers and hepatocarcinoma.Isobolographic analysis demonstrates additive effect of cisplatin and HDIs combined treatment augmenting their anti-cancer activity in lung cancer cell lines.Understanding and targeting resistance mechanisms in NSCLC.Bronchial biopsy specimen as a surrogate for DNA methylation analysis in inoperable lung cancer.Suppression of Adaptive Responses to Targeted Cancer Therapy by Transcriptional Repression.Incidence, Diagnosis, and Management of QT Prolongation Induced by Cancer Therapies: A Systematic Review.Implications of KRAS mutations in acquired resistance to treatment in NSCLC.Recent advances in epigenomics in NSCLC: real-time detection and therapeutic implications.
P2860
Q26773803-82B1B15C-1364-4058-9A25-D503843CCBECQ37301688-44845EF6-F40C-4C65-80BC-573064C42C6DQ37413127-033751BB-5C98-43A9-9D67-9E16466D718DQ37545100-FFD31607-8A2F-4B91-9765-D20CE89EDEE5Q46915997-19B141EB-FF30-4057-939C-06995197F8CDQ47107660-91AA6493-EFAE-4433-B581-5AE2F25BF608Q47671139-B5522A2C-682E-404B-BBF2-D074F6563F22Q49244147-DC8B3AA4-1173-4DBA-8010-163B76E2F5AFQ49787333-8DBCC3E0-C351-45D3-929B-56EA32C4B640Q53048458-E8FFDC24-84C4-45E3-B315-D18C2DFD2966
P2860
Phase I/II study of gefitinib (Iressa(®)) and vorinostat (IVORI) in previously treated patients with advanced non-small cell lung cancer
description
2015 nî lūn-bûn
@nan
2015 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
name
Phase I/II study of gefitinib ...... ced non-small cell lung cancer
@ast
Phase I/II study of gefitinib ...... ced non-small cell lung cancer
@en
type
label
Phase I/II study of gefitinib ...... ced non-small cell lung cancer
@ast
Phase I/II study of gefitinib ...... ced non-small cell lung cancer
@en
prefLabel
Phase I/II study of gefitinib ...... ced non-small cell lung cancer
@ast
Phase I/II study of gefitinib ...... ced non-small cell lung cancer
@en
P2093
P2860
P1476
Phase I/II study of gefitinib ...... ced non-small cell lung cancer
@en
P2093
Geon Kook Lee
Heung Tae Kim
Ji-Youn Han
Jin Young Kim
Kum Hui Hwang
Soo Hyun Lee
Young Joo Lee
P2860
P2888
P304
P356
10.1007/S00280-014-2664-9
P577
2015-01-01T00:00:00Z